Skip to main content
Glama

ScorpTech x402 Tools

Clinical Trials

clinical_trials
Read-onlyIdempotent

Search ClinicalTrials.gov (API v2) by condition, keyword, location, sponsor, recruitment status (or open/closed) and phase. Returns NCT id, title, status, phases, study type, conditions, interventions, lead sponsor, start and completion dates, enrollment, results flag, a short summary and up to 5 sites (ranked by your location), with total count and a page token. Informational only, not medical advice. Price: $0.02 USDC per successful call (x402, Solana). Same tool over HTTPS: GET https://scorptech.it.com/api/x402/v1/clinical-trials

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
sortNorelevance (default), updated, start
termNoOther keywords (drug, NCT id, ...). Alias: q
limitNoStudies per page 1-50 (default 10)
phaseNoComma list: early1, 1, 2, 3, 4, na
statusNoComma list: open, closed, recruiting, not_yet_recruiting, active_not_recruiting, completed, terminated, ...
sponsorNoLead sponsor or collaborator
locationNoCity, state or country
conditionNoCondition or disease, e.g. type 2 diabetes
pageTokenNonextPageToken from a previous response

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only, idempotent, open-world behavior, but the description adds useful operational context: return fields, pagination via page token, site ranking by caller location, an informational-only disclaimer, and per-call pricing. It does not describe error handling or rate limits, but it is substantially richer than the annotations alone.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the search scope and output shape, then appends pricing and endpoint information. It is dense but every sentence serves a purpose; the main sentence is somewhat long but remains readable.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return values and does so thoroughly, including fields, total count, page token, and ranked sites. It also discloses pricing and an alternate HTTPS endpoint, leaving little important context missing for a read-only search tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so all nine parameters are already documented in the schema. The description adds little parameter-level detail beyond restating the filter categories already present, so the baseline of 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource: searching ClinicalTrials.gov by condition, keyword, location, sponsor, status, and phase. It is clearly distinguishable from siblings like pubmed_search or fda_adverse_events because the registry and filter scope are named.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives clear context for when this tool applies by enumerating supported search dimensions and the open/closed status shortcut. It does not explicitly contrast with alternatives such as PubMed or FDA tools, so the agent must infer when not to use it.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources